Comparison of subcutaneous and oral methotrexate initiation in rheumatoid arthritis in current practice

被引：1
作者：
Vidal-Montal, Paola
Thomas, Marion
Combier, Alice [1 ,2 ]
Steelandt, Alexia [1 ,2 ]
Miceli-Richard, Corinne [1 ,2 ]
Molto, Anna [1 ,2 ]
Narvaez, Javier
Nolla, Joan Miquel [1 ]
Allanore, Yannick
Avouac, Jerome [1 ,3 ]
机构：
[1] Bellvitge Univ Hosp, Rheumatol, LHospitalet Llobregat, Spain
[2] Ctr Univ Paris Cite, Cochin Hosp, AP HP, Dept Rheumatol, Paris, France
[3] Univ Paris 05, Hop Cochin, Serv Rhumatol, 27,Rue Faubourg St Jacques, F-75014 Paris, France
来源：
JOINT BONE SPINE | 2023年 / 90卷 / 06期
关键词：
Rheumatoid arthritis; Methotrexate;
D O I：
10.1016/j.jbspin.2023.105620
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Malignant lymphoma associated with rheumatoid arthritis, developing shortly after initiation of oral methotrexate
    Gono, T
    Shimojima, Y
    Hoshi, K
    Yamamoto, K
    Tokuda, T
    Shikama, N
    Matsuda, M
    Ikeda, S
    INTERNAL MEDICINE, 2004, 43 (02) : 135 - 138
  • [12] Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
    Jaime C. Branco
    Anabela Barcelos
    Filipe Pombo de Araújo
    Graça Sequeira
    Inês Cunha
    José Vaz Patto
    Margarida Oliveira
    Margarida Pratas Mateus
    Maura Couto
    Patrícia Nero
    Patrícia Pinto
    Paulo Monteiro
    Walter Castelão
    Jorge Félix
    Diana Ferreira
    João Almeida
    Maria João Silva
    Advances in Therapy, 2016, 33 : 46 - 57
  • [13] Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
    Branco, Jaime C.
    Barcelos, Anabela
    de Araujo, Filipe Pombo
    Sequeira, Graca
    Cunha, Ines
    Patto, Jose Vaz
    Oliveira, Margarida
    Mateus, Margarida Pratas
    Couto, Maura
    Nero, Patricia
    Pinto, Patricia
    Monteiro, Paulo
    Castelao, Walter
    Felix, Jorge
    Ferreira, Diana
    Almeida, Joao
    Silva, Maria Joao
    ADVANCES IN THERAPY, 2016, 33 (01) : 46 - 57
  • [14] Subcutaneous injection of methotrexate: Advantages in the treatment of rheumatoid arthritis
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2023, 33 (04) : 633 - 639
  • [15] An assessment of efficacy and tolerability following switch from oral to subcutaneous methotrexate in patients with rheumatoid arthritis
    Callaghan, C.
    Harmon, C.
    Malm, T.
    Kinnear, M.
    SCOTTISH MEDICAL JOURNAL, 2015, 60 (03) : E15 - E15
  • [16] Effect of Oral to Subcutaneous Switch of Methotrexate on Disease Activity in Rheumatoid Arthritis Patients
    Aktekin, Lale Akbulut
    Eser, Filiz
    Bodur, Hatice
    Tutoglu, Ahmet
    TURKISH JOURNAL OF RHEUMATOLOGY-TURK ROMATOLOJI DERGISI, 2009, 24 (03): : 140 - 143
  • [17] Optimizing Methotrexate Treatment in Rheumatoid Arthritis: The Case for Subcutaneous Methotrexate Prior to Biologics
    Poonam Sharma
    David G. I. Scott
    Drugs, 2015, 75 : 1953 - 1956
  • [18] Efficacy of methotrexate in comparison to biologics in rheumatoid arthritis
    Rau, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (05) : S58 - S64
  • [19] Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting
    Senbel, Eric
    Trope, Sonia
    Herman-Demars, Helene
    Zinovieva, Elena
    Courbeyrette, Agnes
    Clerson, Pierre
    Fardini, Yann
    Flipo, Rene-Marc
    PATIENT PREFERENCE AND ADHERENCE, 2021, 15 : 751 - 760
  • [20] Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial
    Hebing, Renske C. F.
    Lin, Marry
    Calasan, Maja Bulatovic
    Muller, Ittai B.
    Mahmoud, Sohaila
    Heil, Sandra
    Struys, Eduard A.
    van den Bemt, Bart J. F.
    Twisk, Jos W. R.
    Lems, Willem
    Nurmohamed, Michael T.
    Jansen, Gerrit
    de Jonge, Robert
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (04) : 460 - 467
12345